LENZING AG (LEN.DE) Stock Fundamental Analysis

FRA:LEN • AT0000644505

26.85 EUR
-0.1 (-0.37%)
Last: Sep 15, 2025, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Overall LEN gets a fundamental rating of 3 out of 10. We evaluated LEN against 73 industry peers in the Chemicals industry. LEN has a bad profitability rating. Also its financial health evaluation is rather negative. LEN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year LEN has reported negative net income.
  • LEN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: LEN reported negative net income in multiple years.
  • Of the past 5 years LEN 4 years had a positive operating cash flow.
LEN.DE Yearly Net Income VS EBIT VS OCF VS FCFLEN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

  • LEN's Return On Assets of -2.41% is on the low side compared to the rest of the industry. LEN is outperformed by 68.12% of its industry peers.
  • Looking at the Return On Equity, with a value of -9.59%, LEN is doing worse than 72.46% of the companies in the same industry.
  • With a Return On Invested Capital value of 3.19%, LEN perfoms like the industry average, outperforming 50.72% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for LEN is significantly below the industry average of 7.31%.
  • The 3 year average ROIC (1.29%) for LEN is below the current ROIC(3.19%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.41%
ROE -9.59%
ROIC 3.19%
ROA(3y)-5.64%
ROA(5y)-2.94%
ROE(3y)-20.41%
ROE(5y)-11%
ROIC(3y)1.29%
ROIC(5y)1.63%
LEN.DE Yearly ROA, ROE, ROICLEN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • Looking at the Operating Margin, with a value of 6.63%, LEN is in line with its industry, outperforming 55.07% of the companies in the same industry.
  • In the last couple of years the Operating Margin of LEN has declined.
  • LEN's Gross Margin of 20.63% is on the low side compared to the rest of the industry. LEN is outperformed by 71.01% of its industry peers.
  • LEN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.63%
PM (TTM) N/A
GM 20.63%
OM growth 3Y-21.19%
OM growth 5Y-11.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.92%
GM growth 5Y-14.28%
LEN.DE Yearly Profit, Operating, Gross MarginsLEN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LEN is destroying value.
  • Compared to 1 year ago, LEN has about the same amount of shares outstanding.
  • Compared to 5 years ago, LEN has more shares outstanding
  • LEN has a better debt/assets ratio than last year.
LEN.DE Yearly Shares OutstandingLEN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
LEN.DE Yearly Total Debt VS Total AssetsLEN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • Based on the Altman-Z score of 1.23, we must say that LEN is in the distress zone and has some risk of bankruptcy.
  • LEN has a worse Altman-Z score (1.23) than 73.91% of its industry peers.
  • LEN has a debt to FCF ratio of 20.42. This is a negative value and a sign of low solvency as LEN would need 20.42 years to pay back of all of its debts.
  • LEN has a Debt to FCF ratio of 20.42. This is comparable to the rest of the industry: LEN outperforms 53.62% of its industry peers.
  • A Debt/Equity ratio of 1.59 is on the high side and indicates that LEN has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.59, LEN is doing worse than 88.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 20.42
Altman-Z 1.23
ROIC/WACC0.51
WACC6.24%
LEN.DE Yearly LT Debt VS Equity VS FCFLEN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

  • LEN has a Current Ratio of 1.82. This is a normal value and indicates that LEN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.82, LEN is in line with its industry, outperforming 59.42% of the companies in the same industry.
  • A Quick Ratio of 1.21 indicates that LEN should not have too much problems paying its short term obligations.
  • LEN has a Quick ratio (1.21) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.21
LEN.DE Yearly Current Assets VS Current LiabilitesLEN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 80.17% over the past year.
  • The Revenue has been growing slightly by 4.37% in the past year.
  • The Revenue has been growing slightly by 4.82% on average over the past years.
EPS 1Y (TTM)80.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.99%
Revenue 1Y (TTM)4.37%
Revenue growth 3Y6.67%
Revenue growth 5Y4.82%
Sales Q2Q%-0.21%

3.2 Future

  • Based on estimates for the next years, LEN will show a very strong growth in Earnings Per Share. The EPS will grow by 44.12% on average per year.
  • The Revenue is expected to grow by 2.54% on average over the next years.
EPS Next Y-45.85%
EPS Next 2Y27.76%
EPS Next 3Y40.92%
EPS Next 5Y44.12%
Revenue Next Year3.8%
Revenue Next 2Y3.4%
Revenue Next 3Y3.22%
Revenue Next 5Y2.54%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LEN.DE Yearly Revenue VS EstimatesLEN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
LEN.DE Yearly EPS VS EstimatesLEN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 -5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • LEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year LEN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LEN.DE Price Earnings VS Forward Price EarningsLEN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LEN is valued cheaper than 91.30% of the companies in the same industry.
  • 94.20% of the companies in the same industry are more expensive than LEN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.11
EV/EBITDA 4.88
LEN.DE Per share dataLEN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LEN's earnings are expected to grow with 40.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.76%
EPS Next 3Y40.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for LEN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

LENZING AG

FRA:LEN (9/15/2025, 7:00:00 PM)

26.85

-0.1 (-0.37%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-07
Earnings (Next)11-06
Inst Owners15.8%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.04B
Revenue(TTM)2.69B
Net Income(TTM)-120.30M
Analysts49.09
Price Target28.67 (6.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.74
Dividend Growth(5Y)-31.68%
DP-23.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.11%
PT rev (3m)-10.51%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-23.71%
EPS NY rev (3m)-3303.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF 9.11
P/OCF 3.84
P/B 0.83
P/tB 0.84
EV/EBITDA 4.88
EPS(TTM)-3.12
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)2.95
FCFY10.97%
OCF(TTM)6.99
OCFY26.02%
SpS69.76
BVpS32.5
TBVpS31.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.41%
ROE -9.59%
ROCE 4.53%
ROIC 3.19%
ROICexc 4.04%
ROICexgc 4.07%
OM 6.63%
PM (TTM) N/A
GM 20.63%
FCFM 4.22%
ROA(3y)-5.64%
ROA(5y)-2.94%
ROE(3y)-20.41%
ROE(5y)-11%
ROIC(3y)1.29%
ROIC(5y)1.63%
ROICexc(3y)1.51%
ROICexc(5y)2.07%
ROICexgc(3y)1.52%
ROICexgc(5y)2.09%
ROCE(3y)1.84%
ROCE(5y)2.31%
ROICexgc growth 3Y-16.94%
ROICexgc growth 5Y-17.21%
ROICexc growth 3Y-16.83%
ROICexc growth 5Y-17.09%
OM growth 3Y-21.19%
OM growth 5Y-11.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.92%
GM growth 5Y-14.28%
F-Score6
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 20.42
Debt/EBITDA 3.98
Cap/Depr 48.34%
Cap/Sales 5.79%
Interest Coverage 1.71
Cash Conversion 53.81%
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.21
Altman-Z 1.23
F-Score6
WACC6.24%
ROIC/WACC0.51
Cap/Depr(3y)130.66%
Cap/Depr(5y)264.56%
Cap/Sales(3y)14.58%
Cap/Sales(5y)24.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.99%
EPS Next Y-45.85%
EPS Next 2Y27.76%
EPS Next 3Y40.92%
EPS Next 5Y44.12%
Revenue 1Y (TTM)4.37%
Revenue growth 3Y6.67%
Revenue growth 5Y4.82%
Sales Q2Q%-0.21%
Revenue Next Year3.8%
Revenue Next 2Y3.4%
Revenue Next 3Y3.22%
Revenue Next 5Y2.54%
EBIT growth 1Y140.1%
EBIT growth 3Y-15.93%
EBIT growth 5Y-7.56%
EBIT Next Year537.23%
EBIT Next 3Y94.19%
EBIT Next 5Y68.93%
FCF growth 1Y121.3%
FCF growth 3YN/A
FCF growth 5Y207.34%
OCF growth 1Y407.83%
OCF growth 3Y-6.46%
OCF growth 5Y5.68%

LENZING AG / LEN.DE FAQ

What is the ChartMill fundamental rating of LENZING AG (LEN.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to LEN.DE.


What is the valuation status for LEN stock?

ChartMill assigns a valuation rating of 3 / 10 to LENZING AG (LEN.DE). This can be considered as Overvalued.


How profitable is LENZING AG (LEN.DE) stock?

LENZING AG (LEN.DE) has a profitability rating of 2 / 10.


How financially healthy is LENZING AG?

The financial health rating of LENZING AG (LEN.DE) is 3 / 10.


Is the dividend of LENZING AG sustainable?

The dividend rating of LENZING AG (LEN.DE) is 0 / 10 and the dividend payout ratio is -23.82%.